4D制药ADR吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
264 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-06 02:46
286 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-30 02:46
239 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-25 05:35
240 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-24 21:38
241 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-02 06:44
317 0 公告 Notice of Effectiveness 4D制药ADR资讯 04-29 18:47
254 0 公告 [Cover]Correspondence 4D制药ADR资讯 04-26 00:00
250 0 公告 [Cover]SEC-generated letter 4D制药ADR资讯 04-26 00:00
373 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 04-22 04:39
483 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-05 00:44
408 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 04-02 05:26
421 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-01 05:55
375 0 公告 Notice of Effectiveness 4D制药ADR资讯 03-31 19:09
394 0 公告 [Amend] Registration statement by foreign private 4D制药ADR资讯 03-29 05:50
348 0 公告 [Cover]Correspondence 4D制药ADR资讯 03-28 00:00
617 1 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 23:13
459 0 公告 Registration statement by foreign private issuers 4D制药ADR资讯 03-09 06:32
418 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 03-03 07:58
471 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 03-01 06:44
448 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-26 07:33
468 0 公告 [Amend] Report of foreign issuer [Rules 13a-16 and 4D制药ADR资讯 02-19 06:34
492 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
440 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-19 06:26
433 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-18 21:29
486 0 公告 [Amend] Statement of acquisition of beneficial own 4D制药ADR资讯 02-03 23:51
531 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 02-03 07:02
542 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 02-03 05:05
473 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
466 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 01-11 05:00
431 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 01-06 05:15
505 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 12-15 00:46
502 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-15 18:50
446 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-15 05:15
595 0 公告 [Amend] Registration statement for certain foreign 4D制药ADR资讯 10-07 18:26
553 0 公告 Post-Effective amendments for registration stateme 4D制药ADR资讯 10-01 18:51
537 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 10-01 18:42
516 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 10-01 18:31
547 0 公告 Notice of Effectiveness 4D制药ADR资讯 10-01 00:00
586 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-30 18:44
550 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 09-24 05:07
694 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 09-14 19:32
497 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 08-12 03:47
596 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 08-02 23:41
644 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-28 05:48
507 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 07-28 04:50
831 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 07-08 00:29
559 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 06-05 04:17
526 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:36
513 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 05-26 02:17
575 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 05-25 21:10
538 0 公告 Notice of Effectiveness 4D制药ADR资讯 05-25 18:38
573 0 公告 Securities to be offered to employees in employee 4D制药ADR资讯 05-01 06:14
570 0 公告 [Amend] Annual and transition report of foreign pr 4D制药ADR资讯 05-01 05:39
607 0 公告 Registration statement for certain foreign private 4D制药ADR资讯 04-24 04:27
560 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
584 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-19 18:17
557 0 公告 Statement of acquisition of beneficial ownership b 4D制药ADR资讯 04-12 18:19
590 0 公告 Annual and transition report of foreign private is 4D制药ADR资讯 04-02 18:20
608 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 04-01 19:25
576 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 4D制药ADR资讯 03-23 03:21
546 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-19 02:13
618 0 公告 Certification by an exchange approving securities 4D制药ADR资讯 03-18 22:13
503 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-18 05:03
518 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-17 21:54
520 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 03-09 05:35
652 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
568 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 03-01 21:00
577 0 公告 Prospectus [Rule 424(b)(3)] 4D制药ADR资讯 02-26 21:41
561 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:34
537 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-26 21:28
553 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:26
591 0 公告 Notice of Effectiveness 4D制药ADR资讯 02-26 20:15
684 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-25 06:59
409 0 公告 SEC Staff Letter: REDACTED EXHIBIT 4D制药ADR资讯 02-25 00:00
507 0 公告 Registration of securities [Section 12(b)] 4D制药ADR资讯 02-24 07:45
535 0 公告 [Cover]Correspondence 4D制药ADR资讯 02-24 00:00
476 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-19 00:00
459 0 公告 Registration of American Depository Receipt shares 4D制药ADR资讯 02-18 00:00
430 0 公告 [Amend] Registration of securities, foreign privat 4D制药ADR资讯 02-16 00:00
436 0 公告 Prospectuses and communications, business combinat 4D制药ADR资讯 02-08 00:00
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
郑重声明：用户在社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接